Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
News of European HD Network -
Friday 16 March 2007: Symposium on Neuroendocrine Changes in Huntington´s Disease in Leiden, The Netherlands.

Organizers
EHDN and High-Q Foundation


Aims
- To arrange an opportunity for a broader group of scientists and clinicians working with Huntington’s disease in Europe and that are interested in hypothalamus and neuroendocrine factors, to meet and hear the current research from world-leading experts.
- To stimulate new ideas on how to view HD and inspire clinicians to investigate less studied aspects of HD such as sleep disturbances, psychiatric symptoms, weight loss, changes in circadian rhythm etc.
- To identify novel potential mediators of the pathogenesis in HD, which will lead to new projects that would not have been initiated otherwise.

Registration
Registration is possible via email to Åsa Petersen and Marie-Noëlle Witjes-Ané. There is no fee. Participants (aside from the invited speakers) are kindly asked to cover their expenses for travel and accomodation out of their own pockets.

Information about the Symposium

LOCATION AND PROGRAM

Holiday Inn, Leiden, The Netherlands
www.holiday-inn-leiden.com
Haagse Schouwweg 10
2332 KG LEIDEN
+31 (0)71 53 55 555


Trains from Amsterdam-Schiphol Airport arrive to Leiden Central Railway station 6 times per hour. A free shuttle service is available between central station and the hotel in the early morning and late afternoon from Monday to Friday.



Thursday 15 March: arrivals
20.00-22.00
Reception

Friday 16 March: symposium
8.30-9.00 Registration

9.00-9.15

Dr. Åsa Petersén and Prof. Bernhard Landwehrmeyer

Opening remarks


9.15-10.15

Prof. Dick Swaab, Dutch Institute for Neuroscience, Amsterdam, NL

The human hypothalamus
in health and disease

10.15-10.45
Coffee

10.45-11.45

Ahmad Aziz, Leiden University Medical Center, NL

Hypothalamic changes in Huntington’s disease


11.45-12.15

Dr. Marta Valenza, University of Milan, Italy

Dysfunction of the cholesterol biosynthetic pathway in Huntington's disease and neurodegenerative disorders


12.15-13.15 
Lunch

13.15-14.15

Prof. Ruud M Buijs, Biomedicas Institute UNAM, Mexico city

Overview of neuroendocrine regulation

14.15-14.45
Dr. Maria Björkqvist, Lund University, Sweden

Neuroendocrine factors as biomarkers for Huntington's disease

14.45-15.15 Coffee

15.15-15.45
Jorien van der Burg, Lund University, Sweden

Increased energy metabolism in Huntington disease mice


15.45-16.15

Dr. Patrick Weydt, Ulm University, Germany

PGC-1 alpha in the metabolic dysregulation of Huntington's Disease


16.15-16.45
Dr. Sebastiaan Overeem,
Leiden University Medical Center, NL
Narcolepsy and hypothalamic pathology

19.00 Buffet dinner

[back]